Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 8/20 | 0.75 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.66 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.62 |
| ▸ | ACHE | P22303 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | MGAM | O43451 | 1/20 | 0.51 |
| ▸ | IDH1 | O75874 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | SI | P14410 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | FASN | P49327 | 1/20 | 0.51 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.51 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.51 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.49 |
| ▸ | TUBB | P07437 | 1/20 | 0.49 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.49 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.49 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycyrin SCHEMBL29388094 | 1.00 | PTPN1 (0.75) | PTPN1DYRK1APDE4DACHEADORA3 | |
| Glycycoumarin SCHEMBL29390258 | 0.94 | PTPN1 (0.75) | PTPN1DYRK1APDE4DACHEBCHE | |
| Glycycoumarin SCHEMBL759406 | 0.94 | PTPN1 (0.75) | PTPN1DYRK1APDE4DACHEBCHE | |
| SCHEMBL22704765 | 0.86 | PTPN1 (1.00) | PTPN1DYRK1APDE4DACHEADORA3 | |
| SCHEMBL29391195 | 0.86 | PTPN1 (1.00) | PTPN1DYRK1APDE4DACHEADORA3 | |
| Licocoumarone SCHEMBL758659 | 0.79 | PTPN1 (1.00) | PTPN1DYRK1APDE4DBCHETUBB4A | |
| Licocoumarone SCHEMBL30220504 | 0.79 | PTPN1 (1.00) | PTPN1DYRK1APDE4DBCHETUBB4A | |
| SCHEMBL28008322 | 0.78 | ALOX5AP (0.59) | PTPN1DYRK1APDE4DACHEADORA3 | |
| SCHEMBL15941538 | 0.77 | PDE4D (1.00) | PTPN1DYRK1APDE4DACHEADORA3 | |
| Licoricidin SCHEMBL4468990 | 0.76 | PTPN1 (0.70) | PTPN1DYRK1APDE4DACHETUBB4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118841188-A | Mining method of stomach adenocarcinoma resisting action mechanism of Sixisan and application of mining method | 江苏食品药品职业技术学院 | 2024-10-25 | — | — | CN | claimed |
| US-20230276831-A1 | Food/Beverage Article | KIKKOMAN CORPORATION (JP) | 2023-09-07 | — | — | US | claimed |
| EP-4176731-A1 | FOOD/BEVERAGE ARTICLE | Kikkoman Corporation (JP) | 2023-05-10 | — | — | EP | claimed |
| WO-2022030443-A1 | FOOD/BEVERAGE ARTICLE | キッコーマン株式会社 | 2022-02-10 | — | — | WO | claimed |
| WO-2007127791-A2 | NEW PHARMACOLOGICAL METHOD FOR TREATMENT OF NEUROPATHIC PAIN | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2007-11-08 | — | — | WO | claimed |
| US-12629350-B2 | Transthyretin tetramer stabilizing agent, and preventing agent or progression suppressing agent for transthyretin amyloidosis | KANEKA CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-20250113821-A1 | Methods and Compositions for Preserving Tissues and Organs | MASSACHUSETTS GEN HOSPITAL (US) | 2025-04-10 | — | — | US | disclosed |
| US-12239126-B2 | Methods and compositions for preserving tissues and organs | THE GENERAL HOSPITAL CORPORATION (US) | 2025-03-04 | — | — | US | disclosed |
| CN-118841188-A | Mining method of stomach adenocarcinoma resisting action mechanism of Sixisan and application of mining method | 江苏食品药品职业技术学院 | 2024-10-25 | — | — | CN | disclosed |
| US-20230276831-A1 | Food/Beverage Article | KIKKOMAN CORPORATION (JP) | 2023-09-07 | — | — | US | disclosed |
| US-20230276831-A1 | Food/Beverage Article | KIKKOMAN CORPORATION (JP) | 2023-09-07 | — | — | US | disclosed |
| US-20230276831-A1 | Food/Beverage Article | KIKKOMAN CORPORATION (JP) | 2023-09-07 | — | — | US | disclosed |
| US-7888388-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-7888388-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-7524975-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7524975-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| WO-2007127791-A2 | NEW PHARMACOLOGICAL METHOD FOR TREATMENT OF NEUROPATHIC PAIN | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2007-11-08 | — | — | WO | disclosed |
| US-20070249561-A1 | Pharmacological method for treatment of neuropathic pain | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249561-A1 | Pharmacological method for treatment of neuropathic pain | PPARG, PPARA, CNR2 | PTPN1 2713/4885DYRK1A 3268/4885PDE4D 581/4885 |
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | PPARG, PPARA, PPARD | PTPN1 945/4885DYRK1A 3340/4885PDE4D 4132/4885 |
| US-12629350-B2 | Transthyretin tetramer stabilizing agent, and preventing agent or progression suppressing agent for transthyretin amyloidosis | TTR, APOB, ALB | PTPN1 2066/4885DYRK1A 4337/4885PDE4D 4100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.